Alkaline Phosphatase-Controllable and Red Light-Activated RNA Modification Approach for Precise Tumor Suppression
RNA interference (RNAi) has proved to be a promising modality for disease treatment. However, the promise of conventional RNA therapeutics for clinical application is severely impeded by low delivery efficiency and susceptibility of RNAs to serum RNases. Therefore, developing advanced RNAi technolog...
Saved in:
Published in | Journal of the American Chemical Society Vol. 144; no. 50; pp. 23061 - 23072 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
WASHINGTON
American Chemical Society
21.12.2022
Amer Chemical Soc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | RNA interference (RNAi) has proved to be a promising modality for disease treatment. However, the promise of conventional RNA therapeutics for clinical application is severely impeded by low delivery efficiency and susceptibility of RNAs to serum RNases. Therefore, developing advanced RNAi technology is an increasing demand for achieving precise medicine. Herein, for the first time, we propose an alkaline phosphatase (ALP)-controllable and red light-activated RNA modification (ALARM) approach for anti-tumor therapeutic application. An ALP-responsive NIR fluorogenic probe f-RCP consisting of a tumor-targeting cyclic RGD peptide, an ALP-activated photosensitizer CyOP, and an 1O2-susceptible furan module for RNA modification was rationally designed and synthesized. Studies have demonstrated that f-RCP can specifically target to liver carcinoma HepG2 cells and spontaneously emit activated NIR/photoacoustic signals upon cleavage by the ALP enzyme, allowing for sensitive detection of ALP-positive tumors. More notably, we surprisingly found that the capability of f-RCP producing singlet oxygen (1O2) under red light irradiation could be simultaneously unlocked, which can ignite the covalent cyclization reaction between furan and nucleobases of intracellular RNA molecules, leading to significant mitochondrial damage and severe apoptosis of tumor cells, in consequence realizing efficient tumor suppression. Most importantly, the potential therapeutic mechanism was first explored on the transcriptomic level. This delicate ALARM strategy may open up new insights into cancer gene therapy. |
---|---|
AbstractList | RNA interference (RNAi) has proved to be a promising modality for disease treatment. However, the promise of conventional RNA therapeutics for clinical application is severely impeded by low delivery efficiency and susceptibility of RNAs to serum RNases. Therefore, developing advanced RNAi technology is an increasing demand for achieving precise medicine. Herein, for the first time, we propose an alkaline phosphatase (ALP)controllable and red light-activated RNA modification (ALARM) approach for anti-tumor therapeutic application. An ALPresponsive NIR fluorogenic probe f-RCP consisting of a tumortargeting cyclic RGD peptide, an ALP-activated photosensitizer CyOP, and an 1O2-susceptible furan module for RNA modification was rationally designed and synthesized. Studies have demonstrated that f-RCP can specifically target to liver carcinoma HepG2 cells and spontaneously emit activated NIR/photoacoustic signals upon cleavage by the ALP enzyme, allowing for sensitive detection of ALP-positive tumors. More notably, we surprisingly found that the capability of f-RCP producing singlet oxygen (1O2) under red light irradiation could be simultaneously unlocked, which can ignite the covalent cyclization reaction between furan and nucleobases of intracellular RNA molecules, leading to significant mitochondrial damage and severe apoptosis of tumor cells, in consequence realizing efficient tumor suppression. Most importantly, the potential therapeutic mechanism was first explored on the transcriptomic level. This delicate ALARM strategy may open up new insights into cancer gene therapy. RNA interference (RNAi) has proved to be a promising modality for disease treatment. However, the promise of conventional RNA therapeutics for clinical application is severely impeded by low delivery efficiency and susceptibility of RNAs to serum RNases. Therefore, developing advanced RNAi technology is an increasing demand for achieving precise medicine. Herein, for the first time, we propose an alkaline phosphatase (ALP)-controllable and red light-activated RNA modification (ALARM) approach for anti-tumor therapeutic application. An ALP-responsive NIR fluorogenic probe f-RCP consisting of a tumor-targeting cyclic RGD peptide, an ALP-activated photosensitizer CyOP, and an 1O2-susceptible furan module for RNA modification was rationally designed and synthesized. Studies have demonstrated that f-RCP can specifically target to liver carcinoma HepG2 cells and spontaneously emit activated NIR/photoacoustic signals upon cleavage by the ALP enzyme, allowing for sensitive detection of ALP-positive tumors. More notably, we surprisingly found that the capability of f-RCP producing singlet oxygen (1O2) under red light irradiation could be simultaneously unlocked, which can ignite the covalent cyclization reaction between furan and nucleobases of intracellular RNA molecules, leading to significant mitochondrial damage and severe apoptosis of tumor cells, in consequence realizing efficient tumor suppression. Most importantly, the potential therapeutic mechanism was first explored on the transcriptomic level. This delicate ALARM strategy may open up new insights into cancer gene therapy. RNA interference (RNAi) has proved to be a promising modality for disease treatment. However, the promise of conventional RNA therapeutics for clinical application is severely impeded by low delivery efficiency and susceptibility of RNAs to serum RNases. Therefore, developing advanced RNAi technology is an increasing demand for achieving precise medicine. Herein, for the first time, we propose an alkaline phosphatase (ALP)-controllable and red light-activated RNA modification (ALARM) approach for anti-tumor therapeutic application. An ALP-responsive NIR fluorogenic probe -RCP consisting of a tumor-targeting cyclic RGD peptide, an ALP-activated photosensitizer CyOP, and an O -susceptible furan module for RNA modification was rationally designed and synthesized. Studies have demonstrated that -RCP can specifically target to liver carcinoma HepG2 cells and spontaneously emit activated NIR/photoacoustic signals upon cleavage by the ALP enzyme, allowing for sensitive detection of ALP-positive tumors. More notably, we surprisingly found that the capability of -RCP producing singlet oxygen ( O ) under red light irradiation could be simultaneously unlocked, which can ignite the covalent cyclization reaction between furan and nucleobases of intracellular RNA molecules, leading to significant mitochondrial damage and severe apoptosis of tumor cells, in consequence realizing efficient tumor suppression. Most importantly, the potential therapeutic mechanism was first explored on the transcriptomic level. This delicate ALARM strategy may open up new insights into cancer gene therapy. RNA interference (RNAi) has proved to be a promising modality for disease treatment. However, the promise of conventional RNA therapeutics for clinical application is severely impeded by low delivery efficiency and susceptibility of RNAs to serum RNases. Therefore, developing advanced RNAi technology is an increasing demand for achieving precise medicine. Herein, for the first time, we propose an alkaline phosphatase (ALP)-controllable and red light-activated RNA modification (ALARM) approach for anti-tumor therapeutic application. An ALP-responsive NIR fluorogenic probe f-RCP consisting of a tumor-targeting cyclic RGD peptide, an ALP-activated photosensitizer CyOP, and an 1O2-susceptible furan module for RNA modification was rationally designed and synthesized. Studies have demonstrated that f-RCP can specifically target to liver carcinoma HepG2 cells and spontaneously emit activated NIR/photoacoustic signals upon cleavage by the ALP enzyme, allowing for sensitive detection of ALP-positive tumors. More notably, we surprisingly found that the capability of f-RCP producing singlet oxygen (1O2) under red light irradiation could be simultaneously unlocked, which can ignite the covalent cyclization reaction between furan and nucleobases of intracellular RNA molecules, leading to significant mitochondrial damage and severe apoptosis of tumor cells, in consequence realizing efficient tumor suppression. Most importantly, the potential therapeutic mechanism was first explored on the transcriptomic level. This delicate ALARM strategy may open up new insights into cancer gene therapy.RNA interference (RNAi) has proved to be a promising modality for disease treatment. However, the promise of conventional RNA therapeutics for clinical application is severely impeded by low delivery efficiency and susceptibility of RNAs to serum RNases. Therefore, developing advanced RNAi technology is an increasing demand for achieving precise medicine. Herein, for the first time, we propose an alkaline phosphatase (ALP)-controllable and red light-activated RNA modification (ALARM) approach for anti-tumor therapeutic application. An ALP-responsive NIR fluorogenic probe f-RCP consisting of a tumor-targeting cyclic RGD peptide, an ALP-activated photosensitizer CyOP, and an 1O2-susceptible furan module for RNA modification was rationally designed and synthesized. Studies have demonstrated that f-RCP can specifically target to liver carcinoma HepG2 cells and spontaneously emit activated NIR/photoacoustic signals upon cleavage by the ALP enzyme, allowing for sensitive detection of ALP-positive tumors. More notably, we surprisingly found that the capability of f-RCP producing singlet oxygen (1O2) under red light irradiation could be simultaneously unlocked, which can ignite the covalent cyclization reaction between furan and nucleobases of intracellular RNA molecules, leading to significant mitochondrial damage and severe apoptosis of tumor cells, in consequence realizing efficient tumor suppression. Most importantly, the potential therapeutic mechanism was first explored on the transcriptomic level. This delicate ALARM strategy may open up new insights into cancer gene therapy. |
Author | Fang, Jing Lv, Zhengzhong Zhu, Jinfeng Shi, Haibin Li, Jiachen Zhang, Yuqi Xu, Chenjie Zhao, Zhongsheng Cui, Chaoxiang Feng, Yali Wang, Anna Guo, Yirui |
AuthorAffiliation | The Second Affiliated Hospital of Soochow University State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X) and Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions City University of Hong Kong Department of Biomedical Engineering Department of Radiology |
AuthorAffiliation_xml | – name: Department of Radiology – name: State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X) and Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions – name: Department of Biomedical Engineering – name: The Second Affiliated Hospital of Soochow University – name: City University of Hong Kong |
Author_xml | – sequence: 1 givenname: Jing surname: Fang fullname: Fang, Jing organization: State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X) and Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions – sequence: 2 givenname: Yali surname: Feng fullname: Feng, Yali organization: State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X) and Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions – sequence: 3 givenname: Yuqi surname: Zhang fullname: Zhang, Yuqi organization: State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X) and Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions – sequence: 4 givenname: Anna surname: Wang fullname: Wang, Anna organization: State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X) and Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions – sequence: 5 givenname: Jiachen surname: Li fullname: Li, Jiachen organization: State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X) and Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions – sequence: 6 givenname: Chaoxiang surname: Cui fullname: Cui, Chaoxiang organization: The Second Affiliated Hospital of Soochow University – sequence: 7 givenname: Yirui surname: Guo fullname: Guo, Yirui organization: State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X) and Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions – sequence: 8 givenname: Jinfeng surname: Zhu fullname: Zhu, Jinfeng organization: State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X) and Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions – sequence: 9 givenname: Zhengzhong surname: Lv fullname: Lv, Zhengzhong organization: State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X) and Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions – sequence: 10 givenname: Zhongsheng surname: Zhao fullname: Zhao, Zhongsheng organization: State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X) and Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions – sequence: 11 givenname: Chenjie orcidid: 0000-0002-8278-3912 surname: Xu fullname: Xu, Chenjie organization: City University of Hong Kong – sequence: 12 givenname: Haibin orcidid: 0000-0003-2234-9126 surname: Shi fullname: Shi, Haibin email: hbshi@suda.edu.cn organization: State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X) and Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36503221$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkc1v1DAQxS1URLeFG2eUIxKk-CNO4mMUFYq0QFXKOXLsMesla29tB8R_j7ebckAgcbLH83tj-70zdOK8A4SeE3xBMCVvtlLFC6oIrrB4hFaEU1xyQusTtMIY07Jpa3aKzmLc5rKiLXmCTlnNMaOUrNBdN32Tk3VQXG983G9kkhHK3rsU_DTJcYJCOl3cgC7W9usmlZ1K9rtMub752BUfvLbGKpmsd0W33wcv1aYwPhTXAZSNUNzOu1x9nnMPYszYU_TYyCnCs2U9R1_eXt72V-X607v3fbcuJaNVKkdDBWmF1sxowznjmgvScMF0w2QFWKuRUypM3TaVHhtudGsabLgiDaFACTtHL49z86PuZohp2NmoIH_KgZ_jQBvO6rqpBMvoiwWdxx3oYR_sToafw4NNGXh1BH7A6E1UFpyC31j2tRW1wETkHT7Q7f_TvU337vV-dilL6VGqgo8xgBnU0k9B2mkgeDiEPhxCH5bQs-j1H6KHu_6BL8YcDrd-Di7H8Hf0F3wRuWI |
CitedBy_id | crossref_primary_10_1039_D3AN01761C crossref_primary_10_1002_anie_202411598 crossref_primary_10_1021_cbmi_3c00030 crossref_primary_10_1038_s41467_025_56691_3 crossref_primary_10_1002_ange_202317773 crossref_primary_10_1021_cbmi_3c00078 crossref_primary_10_1039_D2CS00999D crossref_primary_10_1002_anie_202410649 crossref_primary_10_1039_D3CC01778H crossref_primary_10_1021_jacs_4c17092 crossref_primary_10_1002_anie_202317773 crossref_primary_10_1021_acsmaterialslett_3c00790 crossref_primary_10_1002_adhm_202304108 crossref_primary_10_1002_anie_202218969 crossref_primary_10_1002_ange_202410649 crossref_primary_10_1021_acsami_4c11112 crossref_primary_10_1007_s11426_023_1606_8 crossref_primary_10_1021_acs_biomac_3c01413 crossref_primary_10_1021_acs_jmedchem_4c00355 crossref_primary_10_1016_j_talanta_2024_126477 crossref_primary_10_1016_j_nantod_2023_102111 crossref_primary_10_1002_ange_202411598 crossref_primary_10_1039_D2SC06413H crossref_primary_10_1039_D3CB00073G crossref_primary_10_1016_j_snb_2024_136178 crossref_primary_10_1002_cbic_202400516 crossref_primary_10_1016_j_cclet_2025_111061 crossref_primary_10_1016_j_nantod_2024_102478 crossref_primary_10_1002_asia_202400189 crossref_primary_10_1021_acs_analchem_3c04033 crossref_primary_10_1039_D3MD00565H crossref_primary_10_1002_asia_202300756 crossref_primary_10_1021_acs_analchem_3c04845 crossref_primary_10_1002_cbic_202300633 crossref_primary_10_1080_21691401_2024_2368033 crossref_primary_10_1002_smo_20240031 crossref_primary_10_1021_acsnano_5c00268 crossref_primary_10_1002_adhm_202403243 crossref_primary_10_1002_ange_202218969 |
Cites_doi | 10.1038/s41467-022-29284-7 10.1021/acsnano.6b07600 10.1021/acsami.1c02122 10.1021/jacs.5b01435 10.1038/s41467-022-29790-8 10.1039/c5cc09248e 10.1038/s41557-020-0514-4 10.1038/s41565-021-00898-0 10.1021/acs.analchem.2c00098 10.1039/c9sc03355f 10.1021/jacs.0c10755 10.1038/nature.2016.20535 10.1021/jacs.8b13628 10.1021/jacs.8b10558 10.1186/s12943-022-01508-w 10.1038/s41563-019-0378-4 10.1021/acs.chemrev.1c00244 10.1021/ja512293f 10.1038/nature13187 10.1039/c7cs00479f 10.1002/adma.202003523 10.1039/d0cs00560f 10.1021/jacs.7b07582 10.1002/adma.201902575 10.1021/jacs.8b05341 10.1021/nn102055s 10.1056/nejmoa2022483 10.1002/anie.202011174 10.1038/s41573-020-0090-8 10.1002/adma.201801570 10.1016/j.cell.2009.02.007 10.1038/s41586-019-1711-4 10.1021/ja500962u 10.1021/acsami.1c21062 10.1021/cr5006793 10.1039/d0cs01261k 10.1021/jacs.0c08996 10.1002/adma.202110618 10.1002/anie.201300754 10.1021/jacs.1c08898 10.1152/ajplung.1999.277.3.l573 10.1038/s41594-019-0200-7 10.1038/s41467-018-04048-4 10.1021/jacs.0c12044 10.1002/anie.202109863 10.1021/ja301901p 10.1021/jacs.1c00570 10.1021/jacs.0c12043 10.1021/jacs.1c08860 10.1021/acs.bioconjchem.8b00749 10.1021/cr500542t 10.1021/acs.jmedchem.9b01927 10.1021/ja800086u 10.1007/s12274-021-3616-4 10.1038/nrd.2018.93 10.1021/acs.jmedchem.0c00840 10.1126/science.aam8526 10.1126/science.1233158 10.1021/acs.bioconjchem.8b00688 10.1021/ja300174v 10.1016/j.chempr.2018.08.003 10.1056/NEJMoa2022483 |
ContentType | Journal Article |
Copyright | 2022 American Chemical Society |
Copyright_xml | – notice: 2022 American Chemical Society |
DBID | AAYXX CITATION 17B 1KM AHQBO BLEPL DTL EGQ CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1021/jacs.2c10409 |
DatabaseName | CrossRef Web of Knowledge Index Chemicus Web of Science - Science Citation Index Expanded - 2022 Web of Science Core Collection Science Citation Index Expanded Web of Science Primary (SCIE, SSCI & AHCI) Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef Web of Science MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | Web of Science MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 1KM name: Index Chemicus url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/woscc/search-with-editions?editions=WOS.IC sourceTypes: Enrichment Source Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry |
EISSN | 1520-5126 |
EndPage | 23072 |
ExternalDocumentID | 36503221 000896901900001 10_1021_jacs_2c10409 a364479660 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Training Program of the Major Research Plan of the National Natural Science Foundation of China; National Natural Science Foundation of China (NSFC) grantid: 91959123 – fundername: National Science Foundation of China; National Natural Science Foundation of China (NSFC) grantid: 22077092 – fundername: Open Project Program of the State Key Laboratory of Radiation Medicine and Protection grantid: GZK1202132; GZK1202140; GZK1202017 – fundername: Priority Academic Program Development of Jiangsu Higher Education Institutions |
GroupedDBID | --- -DZ -ET -~X .DC .K2 4.4 55A 5GY 5RE 5VS 7~N 85S 8W4 AABXI ABFLS ABFRP ABMVS ABPPZ ABPTK ABQRX ABUCX ACGFO ACGFS ACJ ACNCT ACS ADHLV AEESW AENEX AFEFF AGXLV ALMA_UNASSIGNED_HOLDINGS AQSVZ BAANH BKOMP CS3 DU5 EBS ED~ F5P GGK GNL IH2 IH9 JG~ LG6 P2P ROL RXW TAE TAF TN5 UHB UI2 UKR UPT VF5 VG9 VQA W1F WH7 XSW YQT YZZ ZCA ~02 53G AAHBH AAYXX ABBLG ABJNI ABLBI ACBEA AHGAQ CITATION CUPRZ 17B 1KM AAYWT BLEPL DTL GROUPED_WOS_SCIENCE_CITATION_INDEX_EXPANDED GROUPED_WOS_WEB_OF_SCIENCE CGR CUY CVF ECM EIF NPM YIN 7X8 |
ID | FETCH-LOGICAL-a324t-bf29189dd3fdf5535d5917593d73a4e0dcb5229f6874db75fd8f70f5c1712e213 |
IEDL.DBID | ACS |
ISICitedReferencesCount | 37 |
ISICitedReferencesURI | https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=CitingArticles&UT=000896901900001 |
ISSN | 0002-7863 1520-5126 |
IngestDate | Fri Jul 11 07:26:53 EDT 2025 Wed Feb 19 02:25:37 EST 2025 Fri Aug 29 16:19:23 EDT 2025 Tue Jul 22 03:02:15 EDT 2025 Tue Jul 01 03:54:22 EDT 2025 Thu Apr 24 23:05:49 EDT 2025 Fri Dec 23 04:37:03 EST 2022 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 50 |
Keywords | STRATEGY MITOCHONDRIA CROSS-LINKING RECEPTOR SELECTIVE DETECTION DELIVERY PROBES |
Language | English |
License | https://doi.org/10.15223/policy-029 https://doi.org/10.15223/policy-037 https://doi.org/10.15223/policy-045 |
LinkModel | DirectLink |
LogoURL | https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg |
MergedId | FETCHMERGED-LOGICAL-a324t-bf29189dd3fdf5535d5917593d73a4e0dcb5229f6874db75fd8f70f5c1712e213 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-8278-3912 0000-0003-2234-9126 |
PMID | 36503221 |
PQID | 2753667493 |
PQPubID | 23479 |
PageCount | 12 |
ParticipantIDs | webofscience_primary_000896901900001 proquest_miscellaneous_2753667493 pubmed_primary_36503221 crossref_citationtrail_10_1021_jacs_2c10409 crossref_primary_10_1021_jacs_2c10409 webofscience_primary_000896901900001CitationCount acs_journals_10_1021_jacs_2c10409 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20221221 2022-12-21 |
PublicationDateYYYYMMDD | 2022-12-21 |
PublicationDate_xml | – month: 12 year: 2022 text: 20221221 day: 21 |
PublicationDecade | 2020 |
PublicationPlace | WASHINGTON |
PublicationPlace_xml | – name: WASHINGTON – name: United States |
PublicationTitle | Journal of the American Chemical Society |
PublicationTitleAbbrev | J AM CHEM SOC |
PublicationTitleAlternate | J. Am. Chem. Soc |
PublicationYear | 2022 |
Publisher | American Chemical Society Amer Chemical Soc |
Publisher_xml | – name: American Chemical Society – name: Amer Chemical Soc |
References | ref9/cit9 ref45/cit45 ref3/cit3 ref27/cit27 ref56/cit56 ref16/cit16 ref52/cit52 ref23/cit23 ref8/cit8 ref31/cit31 ref59/cit59 ref2/cit2 ref34/cit34 ref37/cit37 ref20/cit20 ref48/cit48 ref60/cit60 ref17/cit17 ref10/cit10 ref35/cit35 ref53/cit53 ref19/cit19 ref21/cit21 ref42/cit42 ref46/cit46 ref49/cit49 ref13/cit13 ref61/cit61 ref24/cit24 ref38/cit38 ref50/cit50 ref54/cit54 ref6/cit6 ref36/cit36 ref18/cit18 ref11/cit11 ref25/cit25 ref29/cit29 ref32/cit32 ref39/cit39 ref14/cit14 ref57/cit57 ref5/cit5 ref51/cit51 ref43/cit43 ref28/cit28 ref40/cit40 ref26/cit26 ref55/cit55 ref12/cit12 ref15/cit15 ref41/cit41 ref58/cit58 ref22/cit22 ref33/cit33 ref4/cit4 ref30/cit30 ref47/cit47 ref1/cit1 ref44/cit44 ref7/cit7 Sun, L (WOS:000463168900014) 2019; 26 Su, ZL (WOS:000784989100008) 2022; 13 Li, J (WOS:000349138600008) 2015; 137 Schmidt, MJ (WOS:000318043600036) 2013; 52 Warner, KD (WOS:000440162900013) 2018; 17 Xie, RS (WOS:000788376600001) 2022; 34 Liu, J (WOS:000481909600027) 2019; 31 Knutson, SD (WOS:000579400400064) 2020; 142 Wang, YY (WOS:000459642100007) 2019; 30 Biffi, A (WOS:000323370600034) 2013; 341 Dunn, SS (WOS:000303362900048) 2012; 134 Childs-Disney, JL (WOS:000447051500020) 2018; 4 Chen, XC (WOS:000750799000016) 2021; 143 Weng, JH (WOS:000715845900048) 2021; 143 Zhang, YB (WOS:000713054600004) 2021; 121 Xu, Z (WOS:000368353600002) 2016; 52 Mitchell, MJ (WOS:000598984300001) 2021; 20 Jackson, LA (WOS:000588782400009) 2020; 383 Thakore, PI (WOS:000430922900004) 2018; 9 Ye, L (WOS:000678460700003) 2022; 15 Yezhelyev, MV (WOS:000257507400030) 2008; 130 Lim, SY (WOS:000336078400046) 2014; 136 Op de Beeck, M (WOS:000305863900006) 2012; 134 Fang, HP (WOS:000446142500019) 2018; 140 Haniff, HS (WOS:000562733000001) 2020; 12 Huang, JG (WOS:000486618800024) 2019; 18 Lächelt, U (WOS:000363002300014) 2015; 115 Wang, Q (WOS:000651748000020) 2021; 143 Liu, HM (WOS:000600926000001) 2021; 33 Yang, JP (WOS:000356316300015) 2015; 115 Chen, J (WOS:000459642100008) 2019; 30 Nie, JJ (WOS:000443807400018) 2018; 30 Ledford, H (WOS:000383098000015) 2016; 537 Kulkarni, JA (WOS:000656429700001) 2021; 16 Liu, JB (WOS:000591755900001) 2021; 60 Cleary, AS (WOS:000333609900053) 2014; 508 Fang, J (WOS:000779305600034) 2022; 94 Knerr, L (WOS:000629075900019) 2021; 143 Ye, SY (WOS:000603395100031) 2020; 142 Zhang, YQ (WOS:000776282500026) 2022; 13 Sharp, PA (WOS:000263688200007) 2009; 136 Yin, L (WOS:000459642000061) 2019; 141 Anzalone, AV (WOS:000501599200056) 2019; 576 Shen, JL (WOS:000429201500004) 2018; 47 Meyer, SM (WOS:000575023000010) 2020; 49 Mao, QL (WOS:000702320500001) 2021; 60 Costales, MG (WOS:000571493400002) 2020; 63 Tang, WT (WOS:000651750000005) 2021; 13 Malek-Adarnian, E (WOS:000413503300034) 2017; 139 Falese, JP (WOS:000624298500001) 2021; 50 Mout, R (WOS:000398014900012) 2017; 11 Piwecka, M (WOS:000411337700036) 2017; 357 Huang, XH (WOS:000283453700055) 2010; 4 Nikan, M (WOS:000562941200036) 2020; 63 Hattori, N (WOS:000082425100017) 1999; 277 Fang, Y (WOS:000614064400007) 2021; 143 Xu, F (WOS:000498611100014) 2019; 10 Wang, AN (WOS:000731610800001) 2021; 13 Costales, MG (WOS:000459642000029) 2019; 141 Liu, L (WOS:000749200200002) 2022; 21 Sun, Q (WOS:000354910500026) 2015; 137 |
References_xml | – ident: ref14/cit14 doi: 10.1038/s41467-022-29284-7 – ident: ref20/cit20 doi: 10.1021/acsnano.6b07600 – ident: ref21/cit21 doi: 10.1021/acsami.1c02122 – ident: ref44/cit44 doi: 10.1021/jacs.5b01435 – ident: ref49/cit49 doi: 10.1038/s41467-022-29790-8 – ident: ref61/cit61 doi: 10.1039/c5cc09248e – ident: ref37/cit37 doi: 10.1038/s41557-020-0514-4 – ident: ref6/cit6 doi: 10.1038/s41565-021-00898-0 – ident: ref57/cit57 doi: 10.1021/acs.analchem.2c00098 – ident: ref59/cit59 doi: 10.1039/c9sc03355f – ident: ref52/cit52 doi: 10.1021/jacs.0c10755 – ident: ref1/cit1 doi: 10.1038/nature.2016.20535 – ident: ref58/cit58 doi: 10.1021/jacs.8b13628 – ident: ref36/cit36 doi: 10.1021/jacs.8b10558 – ident: ref46/cit46 doi: 10.1186/s12943-022-01508-w – ident: ref55/cit55 doi: 10.1038/s41563-019-0378-4 – ident: ref28/cit28 doi: 10.1021/acs.chemrev.1c00244 – ident: ref25/cit25 doi: 10.1021/ja512293f – ident: ref2/cit2 doi: 10.1038/nature13187 – ident: ref18/cit18 doi: 10.1039/c7cs00479f – ident: ref17/cit17 doi: 10.1002/adma.202003523 – ident: ref30/cit30 doi: 10.1039/d0cs00560f – ident: ref34/cit34 doi: 10.1021/jacs.7b07582 – ident: ref26/cit26 doi: 10.1002/adma.201902575 – ident: ref22/cit22 doi: 10.1021/jacs.8b05341 – ident: ref54/cit54 doi: 10.1021/nn102055s – ident: ref11/cit11 doi: 10.1056/nejmoa2022483 – ident: ref24/cit24 doi: 10.1002/anie.202011174 – ident: ref3/cit3 doi: 10.1038/s41573-020-0090-8 – ident: ref12/cit12 doi: 10.1002/adma.201801570 – ident: ref27/cit27 doi: 10.1016/j.cell.2009.02.007 – ident: ref19/cit19 doi: 10.1038/s41586-019-1711-4 – ident: ref60/cit60 doi: 10.1021/ja500962u – ident: ref5/cit5 doi: 10.1021/acsami.1c21062 – ident: ref9/cit9 doi: 10.1021/cr5006793 – ident: ref41/cit41 doi: 10.1039/d0cs01261k – ident: ref47/cit47 doi: 10.1021/jacs.0c08996 – ident: ref13/cit13 doi: 10.1002/adma.202110618 – ident: ref51/cit51 doi: 10.1002/anie.201300754 – ident: ref56/cit56 doi: 10.1021/jacs.1c08898 – ident: ref53/cit53 doi: 10.1152/ajplung.1999.277.3.l573 – ident: ref45/cit45 doi: 10.1038/s41594-019-0200-7 – ident: ref15/cit15 doi: 10.1038/s41467-018-04048-4 – ident: ref33/cit33 doi: 10.1021/jacs.0c12044 – ident: ref4/cit4 doi: 10.1002/anie.202109863 – ident: ref50/cit50 doi: 10.1021/ja301901p – ident: ref48/cit48 doi: 10.1021/jacs.1c00570 – ident: ref32/cit32 doi: 10.1021/jacs.0c12043 – ident: ref38/cit38 doi: 10.1021/jacs.1c08860 – ident: ref10/cit10 doi: 10.1021/acs.bioconjchem.8b00749 – ident: ref7/cit7 doi: 10.1021/cr500542t – ident: ref39/cit39 doi: 10.1021/acs.jmedchem.9b01927 – ident: ref43/cit43 doi: 10.1021/ja800086u – ident: ref42/cit42 doi: 10.1007/s12274-021-3616-4 – ident: ref35/cit35 doi: 10.1038/nrd.2018.93 – ident: ref31/cit31 doi: 10.1021/acs.jmedchem.0c00840 – ident: ref29/cit29 doi: 10.1126/science.aam8526 – ident: ref8/cit8 doi: 10.1126/science.1233158 – ident: ref23/cit23 doi: 10.1021/acs.bioconjchem.8b00688 – ident: ref16/cit16 doi: 10.1021/ja300174v – ident: ref40/cit40 doi: 10.1016/j.chempr.2018.08.003 – volume: 49 start-page: 7167 year: 2020 ident: WOS:000575023000010 article-title: Small molecule recognition of disease-relevant RNA structures publication-title: CHEMICAL SOCIETY REVIEWS doi: 10.1039/d0cs00560f – volume: 30 start-page: ARTN 1801570 year: 2018 ident: WOS:000443807400018 article-title: Unlockable Nanocomplexes with Self-Accelerating Nucleic Acid Release for Effective Staged Gene Therapy of Cardiovascular Diseases publication-title: ADVANCED MATERIALS doi: 10.1002/adma.201801570 – volume: 50 start-page: 2224 year: 2021 ident: WOS:000624298500001 article-title: Targeting RNA with small molecules: from fundamental principles towards the clinic publication-title: CHEMICAL SOCIETY REVIEWS doi: 10.1039/d0cs01261k – volume: 9 start-page: ARTN 1674 year: 2018 ident: WOS:000430922900004 article-title: RNA-guided transcriptional silencing in vivo with S. aureus CRISPR-Cas9 repressors publication-title: NATURE COMMUNICATIONS doi: 10.1038/s41467-018-04048-4 – volume: 139 start-page: 14542 year: 2017 ident: WOS:000413503300034 article-title: 4′-C-Methoxy-2′-deoxy-2′-fluoro Modified Ribonucleotides Improve Metabolic Stability and Elicit Efficient RNAi-Mediated Gene Silencing publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY doi: 10.1021/jacs.7b07582 – volume: 141 start-page: 3265 year: 2019 ident: WOS:000459642000061 article-title: Quantitatively Visualizing Tumor-Related Protease Activity in Vivo Using a Ratiometric Photoacoustic Probe publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY doi: 10.1021/jacs.8b13628 – volume: 13 start-page: ARTN 1685 year: 2022 ident: WOS:000776282500026 article-title: A hydrogen sulphide-responsive and depleting nanoplatform for cancer photodynamic therapy publication-title: NATURE COMMUNICATIONS doi: 10.1038/s41467-022-29284-7 – volume: 18 start-page: 1133 year: 2019 ident: WOS:000486618800024 article-title: Molecular optical imaging probes for early diagnosis of drug-induced acute kidney injury publication-title: NATURE MATERIALS doi: 10.1038/s41563-019-0378-4 – volume: 52 start-page: 1094 year: 2016 ident: WOS:000368353600002 article-title: Fluorescent probes for the selective detection of chemical species inside mitochondria publication-title: CHEMICAL COMMUNICATIONS doi: 10.1039/c5cc09248e – volume: 16 start-page: 630 year: 2021 ident: WOS:000656429700001 article-title: The current landscape of nucleic acid therapeutics publication-title: NATURE NANOTECHNOLOGY doi: 10.1038/s41565-021-00898-0 – volume: 143 start-page: 1296 year: 2021 ident: WOS:000614064400007 article-title: Spherical Nucleic Acids for Topical Treatment of Hyperpigmentation publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY doi: 10.1021/jacs.0c12044 – volume: 121 start-page: 12181 year: 2021 ident: WOS:000713054600004 article-title: Lipids and Lipid Derivatives for RNA Delivery publication-title: CHEMICAL REVIEWS doi: 10.1021/acs.chemrev.1c00244 – volume: 60 start-page: 23805 year: 2021 ident: WOS:000702320500001 article-title: Aggregation of Gold Nanoparticles Triggered by Hydrogen Peroxide-Initiated Chemiluminescence for Activated Tumor Theranostics publication-title: ANGEWANDTE CHEMIE-INTERNATIONAL EDITION doi: 10.1002/anie.202109863 – volume: 21 start-page: ARTN 32 year: 2022 ident: WOS:000749200200002 article-title: Insights into N6-methyladenosine and programmed cell death in cancer publication-title: MOLECULAR CANCER doi: 10.1186/s12943-022-01508-w – volume: 11 start-page: 2452 year: 2017 ident: WOS:000398014900012 article-title: Direct Cytosolic Delivery of CRISPR/Cas9-Ribonucleoprotein for Efficient Gene Editing publication-title: ACS NANO doi: 10.1021/acsnano.6b07600 – volume: 30 start-page: 338 year: 2019 ident: WOS:000459642100008 article-title: Polycations for Gene Delivery: Dilemmas and Solutions publication-title: BIOCONJUGATE CHEMISTRY doi: 10.1021/acs.bioconjchem.8b00688 – volume: 13 start-page: ARTN 2165 year: 2022 ident: WOS:000784989100008 article-title: TRMT6/61A-dependent base methylation of tRNA-derived fragments regulates gene-silencing activity and the unfolded protein response in bladder cancer publication-title: NATURE COMMUNICATIONS doi: 10.1038/s41467-022-29790-8 – volume: 31 start-page: ARTN 1902575 year: 2019 ident: WOS:000481909600027 article-title: Fast and Efficient CRISPR/Cas9 Genome Editing In Vivo Enabled by Bioreducible Lipid and Messenger RNA Nanoparticles publication-title: ADVANCED MATERIALS doi: 10.1002/adma.201902575 – volume: 130 start-page: 9006 year: 2008 ident: WOS:000257507400030 article-title: Proton-sponge coated quantum dots for siRNA delivery and intracellular imaging publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY doi: 10.1021/ja800086u – volume: 143 start-page: 18294 year: 2021 ident: WOS:000715845900048 article-title: An Activatable Near-Infrared Fluorescence Probe for in Vivo Imaging of Acute Kidney Injury by Targeting Phosphatidylserine and Caspase-3 publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY doi: 10.1021/jacs.1c08898 – volume: 143 start-page: 6895 year: 2021 ident: WOS:000651748000020 article-title: Orthogonal Demethylase-Activated Deoxyribozyme for Intracellular Imaging and Gene Regulation publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY doi: 10.1021/jacs.1c00570 – volume: 137 start-page: 1412 year: 2015 ident: WOS:000349138600008 article-title: Self-assembly of DNA Nanohydrogels with Controllable Size and Stimuli-Responsive Property for Targeted Gene Regulation Therapy publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY doi: 10.1021/ja512293f – volume: 34 start-page: ARTN 2110618 year: 2022 ident: WOS:000788376600001 article-title: pH-Responsive Polymer Nanoparticles for Efficient Delivery of Cas9 Ribonucleoprotein With or Without Donor DNA publication-title: ADVANCED MATERIALS doi: 10.1002/adma.202110618 – volume: 15 start-page: 1135 year: 2022 ident: WOS:000678460700003 article-title: Enhanced endosomal escape of dendrigraft poly-L-lysine polymers for the efficient gene therapy of breast cancer publication-title: NANO RESEARCH doi: 10.1007/s12274-021-3616-4 – volume: 63 start-page: 8471 year: 2020 ident: WOS:000562941200036 article-title: Targeted Delivery of Antisense Oligonucleotides Using Neurotensin Peptides publication-title: JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1021/acs.jmedchem.0c00840 – volume: 10 start-page: 10586 year: 2019 ident: WOS:000498611100014 article-title: Hypoxia-activated NIR photosensitizer anchoring in the mitochondria for photodynamic therapy publication-title: CHEMICAL SCIENCE doi: 10.1039/c9sc03355f – volume: 20 start-page: 101 year: 2021 ident: WOS:000598984300001 article-title: Engineering precision nanoparticles for drug delivery publication-title: NATURE REVIEWS DRUG DISCOVERY doi: 10.1038/s41573-020-0090-8 – volume: 115 start-page: 11043 year: 2015 ident: WOS:000363002300014 article-title: Nucleic Acid Therapeutics Using Polyplexes: A Journey of 50 Years (and Beyond) publication-title: CHEMICAL REVIEWS doi: 10.1021/cr5006793 – volume: 60 start-page: 1853 year: 2021 ident: WOS:000591755900001 article-title: Branched Antisense and siRNA Co-Assembled Nanoplatform for Combined Gene Silencing and Tumor Therapy publication-title: ANGEWANDTE CHEMIE-INTERNATIONAL EDITION doi: 10.1002/anie.202011174 – volume: 33 start-page: ARTN 2003523 year: 2021 ident: WOS:000600926000001 article-title: Nanoassemblies with Effective Serum Tolerance Capability Achieving Robust Gene Silencing Efficacy for Breast Cancer Gene Therapy publication-title: ADVANCED MATERIALS doi: 10.1002/adma.202003523 – volume: 30 start-page: 325 year: 2019 ident: WOS:000459642100007 article-title: Enhancing the In Vitro and In Vivo Stabilities of Polymeric Nucleic Acid Delivery Nanosystems publication-title: BIOCONJUGATE CHEMISTRY doi: 10.1021/acs.bioconjchem.8b00749 – volume: 141 start-page: 2960 year: 2019 ident: WOS:000459642000029 article-title: A Designed Small Molecule Inhibitor of a Non-Coding RNA Sensitizes HER2 Negative Cancers to Herceptin publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY doi: 10.1021/jacs.8b10558 – volume: 26 start-page: 322 year: 2019 ident: WOS:000463168900014 article-title: RNA structure maps across mammalian cellular compartments publication-title: NATURE STRUCTURAL & MOLECULAR BIOLOGY doi: 10.1038/s41594-019-0200-7 – volume: 341 start-page: 864 year: 2013 ident: WOS:000323370600034 article-title: Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy publication-title: SCIENCE doi: 10.1126/science.1233158 – volume: 13 start-page: 59787 year: 2021 ident: WOS:000731610800001 article-title: Assembly Transformation Jointly Driven by the LAP Enzyme and GSH Boosting Theranostic Capability for Effective Tumor Therapy publication-title: ACS APPLIED MATERIALS & INTERFACES doi: 10.1021/acsami.1c21062 – volume: 142 start-page: 17766 year: 2020 ident: WOS:000579400400064 article-title: Thermoreversible Control of Nucleic Acid Structure and Function with Glyoxal Caging publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY doi: 10.1021/jacs.0c08996 – volume: 508 start-page: 113 year: 2014 ident: WOS:000333609900053 article-title: Tumour cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers publication-title: NATURE doi: 10.1038/nature13187 – volume: 140 start-page: 11992 year: 2018 ident: WOS:000446142500019 article-title: Molecular Strings Significantly Improved the Gene Transfection Efficiency of Polycations publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY doi: 10.1021/jacs.8b05341 – volume: 143 start-page: 3416 year: 2021 ident: WOS:000629075900019 article-title: Glucagon Like Peptide 1 Receptor Agonists for Targeted Delivery of Antisense Oligonucleotides to Pancreatic Beta Cell publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY doi: 10.1021/jacs.0c12043 – volume: 17 start-page: 547 year: 2018 ident: WOS:000440162900013 article-title: Principles for targeting RNA with drug-like small molecules publication-title: NATURE REVIEWS DRUG DISCOVERY doi: 10.1038/nrd.2018.93 – volume: 47 start-page: 1969 year: 2018 ident: WOS:000429201500004 article-title: Engineering functional inorganic-organic hybrid systems: advances in siRNA therapeutics publication-title: CHEMICAL SOCIETY REVIEWS doi: 10.1039/c7cs00479f – volume: 383 start-page: 1920 year: 2020 ident: WOS:000588782400009 article-title: An mRNA Vaccine against SARS-CoV-2-Preliminary Report publication-title: NEW ENGLAND JOURNAL OF MEDICINE doi: 10.1056/NEJMoa2022483 – volume: 12 start-page: 952 year: 2020 ident: WOS:000562733000001 article-title: Design of a small molecule that stimulates vascular endothelial growth factor A enabled by screening RNA fold-small molecule interactions publication-title: NATURE CHEMISTRY doi: 10.1038/s41557-020-0514-4 – volume: 576 start-page: 149 year: 2019 ident: WOS:000501599200056 article-title: Search-and-replace genome editing without double-strand breaks or donor DNA publication-title: NATURE doi: 10.1038/s41586-019-1711-4 – volume: 115 start-page: 5274 year: 2015 ident: WOS:000356316300015 article-title: Surface-Engineered Dendrimers in Gene Delivery publication-title: CHEMICAL REVIEWS doi: 10.1021/cr500542t – volume: 52 start-page: 4690 year: 2013 ident: WOS:000318043600036 article-title: Red-Light-Controlled ProteinRNA Crosslinking with a Genetically Encoded Furan publication-title: ANGEWANDTE CHEMIE-INTERNATIONAL EDITION doi: 10.1002/anie.201300754 – volume: 537 start-page: 288 year: 2016 ident: WOS:000383098000015 article-title: Wishlist set for cancer 'moonshot' publication-title: NATURE – volume: 357 start-page: ARTN eaam8526 year: 2017 ident: WOS:000411337700036 article-title: Loss of a mammalian circular RNA locus causes miRNA deregulation and affects brain function publication-title: SCIENCE doi: 10.1126/science.aam8526 – volume: 134 start-page: 7423 year: 2012 ident: WOS:000303362900048 article-title: Reductively Responsive siRNA-Conjugated Hydrogel Nanoparticles for Gene Silencing publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY doi: 10.1021/ja300174v – volume: 136 start-page: 577 year: 2009 ident: WOS:000263688200007 article-title: The Centrality of RNA publication-title: CELL doi: 10.1016/j.cell.2009.02.007 – volume: 277 start-page: L573 year: 1999 ident: WOS:000082425100017 article-title: Participation of urokinase-type plasminogen activator receptor in the clearance of fibrin from the lung publication-title: AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY – volume: 136 start-page: 7018 year: 2014 ident: WOS:000336078400046 article-title: Tunable Heptamethine-Azo Dye Conjugate as an NIR Fluorescent Probe for the Selective Detection of Mitochondria! Glutathione over Cysteine and Homocysteine publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY doi: 10.1021/ja500962u – volume: 4 start-page: 5887 year: 2010 ident: WOS:000283453700055 article-title: A Reexamination of Active and Passive Tumor Targeting by Using Rod-Shaped Gold Nanocrystals and Covalently Conjugated Peptide Ligands publication-title: ACS NANO doi: 10.1021/nn102055s – volume: 13 start-page: 20974 year: 2021 ident: WOS:000651750000005 article-title: A Nucleic Acid/Gold Nanorod-Based Nanoplatform for Targeted Gene Editing and Combined Tumor Therapy publication-title: ACS APPLIED MATERIALS & INTERFACES doi: 10.1021/acsami.1c02122 – volume: 142 start-page: 21502 year: 2020 ident: WOS:000603395100031 article-title: Red Light-Initiated Cross-Linking of NIR Probes to Cytoplasmic RNA: An Innovative Strategy for Prolonged Imaging and Unexpected Tumor Suppression publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY doi: 10.1021/jacs.0c10755 – volume: 143 start-page: 20779 year: 2021 ident: WOS:000750799000016 article-title: Monitoring and Modulating mtDNA G-Quadruplex Dynamics Reveal Its Close Relationship to Cell Glycolysis publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY doi: 10.1021/jacs.1c08860 – volume: 137 start-page: 6000 year: 2015 ident: WOS:000354910500026 article-title: A Collaborative Assembly Strategy for Tumor-Targeted siRNA Delivery publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY doi: 10.1021/jacs.5b01435 – volume: 63 start-page: 8880 year: 2020 ident: WOS:000571493400002 article-title: How We Think about Targeting RNA with Small Molecules publication-title: JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1021/acs.jmedchem.9b01927 – volume: 134 start-page: 10737 year: 2012 ident: WOS:000305863900006 article-title: Sequence Specific DNA Cross-Linking Triggered by Visible Light publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY doi: 10.1021/ja301901p – volume: 4 start-page: 2384 year: 2018 ident: WOS:000447051500020 article-title: A Massively Parallel Selection of Small Molecule-RNA Motif Binding Partners Informs Design of an Antiviral from Sequence publication-title: CHEM doi: 10.1016/j.chempr.2018.08.003 – volume: 94 start-page: 5149 year: 2022 ident: WOS:000779305600034 article-title: In Vivo Quantitative Assessment of a Radiation Dose Based on Ratiometric Photoacoustic Imaging of Tumor Apoptosis publication-title: ANALYTICAL CHEMISTRY doi: 10.1021/acs.analchem.2c00098 |
SSID | ssj0004281 |
Score | 2.5531003 |
Snippet | RNA interference (RNAi) has proved to be a promising modality for disease treatment. However, the promise of conventional RNA therapeutics for clinical... |
Source | Web of Science |
SourceID | proquest pubmed webofscience crossref acs |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 23061 |
SubjectTerms | Alkaline Phosphatase Chemistry Chemistry, Multidisciplinary Fluorescent Dyes - chemistry Humans Light Neoplasms Physical Sciences RNA Science & Technology |
Title | Alkaline Phosphatase-Controllable and Red Light-Activated RNA Modification Approach for Precise Tumor Suppression |
URI | http://dx.doi.org/10.1021/jacs.2c10409 http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=FullRecord&UT=000896901900001 https://www.ncbi.nlm.nih.gov/pubmed/36503221 https://www.proquest.com/docview/2753667493 |
Volume | 144 |
WOS | 000896901900001 |
WOSCitedRecordID | wos000896901900001 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LT9wwELYqemgvfUFL-pKR6Al5tbbjJD5GUSlCBSEeEreVn0JiyUKTvfTXdyaPhUJROTqZRIpnnPlGM_MNIduFDanOomM6RMFS6w0zwURWCOmUsXFqDDYKHxxme2fp_rk6vy2QvZ_BF8gP5JqJcBA2YJ_ec5HB-UUIVJ3c9j-Kgo8wNy8yORS4338aHZBr_nZAD1DlPx1Q52x2X5MfY8tOX2NyOVm2duJ-P2Rw_M93vCGvBrxJy95A3pJnoX5HXlTjmLd1clPOLw1iTXp0sWiuL0wLfo1VfQX7HBurqKk9PQ6e_uxIR0rXTUSD9fFhSQ8WHouNOv3SciAop4CE6RHyZjSBni6vYIXTQ_uS23qDnO1-P6322DCHgRmAWy2zUWheaO9l9FEpqbyCIE9p6XNp0jD1zgKK0xE0k3qbq-iLmE-jcjznIggu35O1elGHTUINAq6Q6ymgxjRzED9JZz2eVPClStqEbME2zYZz1My6FLmAEAWvDpuXkJ1RgTM3EJnjPI35I9LfVtLXPYHHI3Jboy3MQAOYNjF1WCxBACK6LMtTLRPyoTeS1ZskAFz4JfKEbN-1mtV9hFgaZ37pLo2SEP4UsWr4KqQlaD8-YUs-kZcC2zK4YIJ_Jmvtr2X4AmCptV-7k_IHv3QNNg |
linkProvider | American Chemical Society |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELZQeygXKM-G8nClckKp1nacxMcoolpgd1WVrdRb5KcqdckWkr3w6zuTZLdQqLRHOxMrtseZb-SZbwg5zo1PVBpsrHzgcWKcjrXXIc65sFKbMNIaE4Wns3R8kXy9lJdDsjrmwsBHNDBS013i37ELIE0QdHIL3gOm6-0CDuGo0EX5_S4NkudsjXazPBVDnPv9t9EO2eZvO_QPuPyvHepszulTMtt8bRdqcn2yas2J_X2PyHHr6eyTJwP6pEWvLs_II18_J3vluujbC_KzWFxrRJ707GrZ3FzpFqxcXPbx7AtMs6K6dvTcOzrpKEgK29VHg_b5rKDTpcPQo263aTHQlVPAxfQMWTQaT-erH9DCWqJ9AG79klycfp6X43ioyhBrAF9tbAJXLFfOieCClEI6CS6fVMJlQid-5KwBTKdCmmeJM5kMLg_ZKEjLMsY9Z-IV2amXtT8gVCP88pkaAYZMUgvelLDG4bkFyyqFicgRLFM1nKqm6i7MOTgs2DssXkQ-rfexsgOtOVbXWDwg_XEjfdPTeTwgd7RWiQp2AC9RdO2XKxAA_y5Ns0SJiLzudWUzkgC4Cz9IFpHjP5Vn8xwBl8IKYKq7VIkI20asHGaFJAXtmy2W5APZG8-nk2ryZfbtkDzmmLDBeMzZW7LT_lr5dwCjWvO-Ozy3XwQVlw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELaqIgEX3pTwdKVyQqnWdpzExyiwKtCuVksr9Rb5qUpdsgvJXvj1zOSxQKFSOSaZWLE9znyjmfmGkIPc-ESlwcbKBx4nxulYex3inAsrtQkTrbFQ-GSWHp0ln87l-Q5hYy0MfEQDIzVdEB9P9dqFgWEAqYLgAbfgQWDJ3i2M2KFSF-WXX6WQPGcj4s3yVAy57lffRltkmz9t0V8A85-2qLM70_tksf3iLt3k8nDTmkP74wqZ439N6QG5N6BQWvRq85Ds-PoRuVOOzd8ek2_F8lIjAqXzi1WzvtAtWLu47PPal1huRXXt6MI7etxRkRS265MG14tZQU9WDlOQul2nxUBbTgEf0zmyaTSenm6-whX2FO0Tcesn5Gz64bQ8iofuDLEGENbGJnDFcuWcCC5IKaST4PpJJVwmdOInzhrAdiqkeZY4k8ng8pBNgrQsY9xzJp6S3XpV-2eEaoRhPlMTwJJJasGrEtY4PL9gYaUwEdmHZaqG09VUXeCcg-OCd4fFi8i7cS8rO9CbY5eN5TXSb7fS657W4xq5_VEtKtgBDKbo2q82IAB-XppmiRIR2ev1ZTuSANgLP0oWkYPfFWj7HIGXwk5gqguuRITdRKwcZoVkBe3zGyzJG3J7_n5aHX-cfX5B7nKs22A85uwl2W2_b_wrQFOted2dn59qihga |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Alkaline+Phosphatase-Controllable+and+Red+Light-Activated+RNA+Modification+Approach+for+Precise+Tumor+Suppression&rft.jtitle=Journal+of+the+American+Chemical+Society&rft.au=Fang%2C+Jing&rft.au=Feng%2C+Yali&rft.au=Zhang%2C+Yuqi&rft.au=Wang%2C+Anna&rft.date=2022-12-21&rft.pub=American+Chemical+Society&rft.issn=0002-7863&rft.eissn=1520-5126&rft.volume=144&rft.issue=50&rft.spage=23061&rft.epage=23072&rft_id=info:doi/10.1021%2Fjacs.2c10409&rft.externalDocID=a364479660 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-7863&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-7863&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-7863&client=summon |